Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization.Acinetobacter infections have increased and gained attention because of the organism's prolonged environmental survival and propensity to develop antimicrobial antimicrobial /an·ti·mi·cro·bi·al/ (-mi-kro´be-al)
1. killing microorganisms or suppressing their multiplication or growth.
2. an agent with such effects. drug resistance. The effect of multidrug-resistant (MDR MDR,
n See multidrug resistance.
n the abbreviation for minimum daily requirement, specifically the Minimum Daily Requirements for Specific Nutrients compiled by the United States Food and Drug Administration. ) Acinetobacter infection on clinical outcomes has not been reported. A retrospective, matched cohort investigation was performed at 2 Baltimore hospitals to examine outcomes of patients with MDR Acinetobacter infection compared with patients with susceptible Acinetobacter infections and patients without Acinetobacter infections. Multivariable analysis controlling for severity of illness and underlying disease identified an independent association between patients with MDR Acinetobacter infection (n = 96) and increased hospital and intensive care unit length of stay compared with 91 patients with susceptible Acinetobacter infection (odds ratio [OR] 2.5, 95% confidence interval confidence interval,
n a statistical device used to determine the range within which an acceptable datum would fall. Confidence intervals are usually expressed in percentages, typically 95% or 99%. [CI] 1.2-5.2 and OR 2.1, 95% CI 1.0-4.3] respectively) and 89 uninfected patients (OR 2.5, 95% CI 1.2-5.4 and OR 4.2, 95% CI 1.5-11.6] respectively). Increased hospitalization hospitalization /hos·pi·tal·iza·tion/ (hos?pi-t'l-i-za´shun)
1. the placing of a patient in a hospital for treatment.
2. the term of confinement in a hospital. associated with MDR Acinetobacter infection emphasizes the need for infection control strategies to prevent cross-transmission in healthcare settings.
Acinetobacter species are aerobic gram-negative bacilli bacilli /ba·cil·li/ (bah-sil´i) plural of bacillus.
see bacillus. that can cause healthcare-associated infections and can survive for prolonged periods in the environment and on the hands of healthcare workers (1-3). The proportion of healthcare-associated infections caused by Acinetobacter spp Acinetobacter spp Bacteriology A widely distributed bacterium found in moist hospital environments, which may establish itself in the respiratory flora and on the skin of Pts with prolonged hospitalization, often via contaminated medical instruments–eg, . has increased over the past decade in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. (4). Furthermore, Acinetobacter infections have become increasingly difficult to treat because of the emergence of strains resistant to all drugs or all but 1 commonly prescribed antimicrobial drug (5-7). These multidrug-resistant (MDR) strains are sometimes susceptible only to polymyxins (colistin colistin /co·lis·tin/ (ko-lis´tin) an antibiotic produced by Bacillus polymyxa var. colistinus, related to polymyxin and effective against many gram-negative bacteria; used as the sulfate salt. and polymyxin B Polymyxin B (also referred to as PMB) are antibiotics primarily used for resistant gram negative infections. Polymyxins bind to the cell membrane and alters its structure making it more permeable. The resulting water uptake leads to cell death. ), a class of antimicrobial drugs that has not been in widespread use for several decades and is more toxic than most currently used antimicrobial drugs. Outbreaks caused by MDR Acinetobacter have been reported in hospitals all over the world; more recently, they have become a serious problem in military medical facilities (7-9).
Although drug resistance of Acinetobacter is a recognized problem, the effect of MDR Acinetobacter infections on patient outcomes remains controversial. Previous studies on clinical outcomes of patients infected with Acinetobacter have yielded conflicting results and are limited by methodologic challenges that include small sample sizes, failure to control for severity of illness before infection, and failure to exclude patients colonized Colonized
This occurs when a microorganism is found on or in a person without causing a disease.
Mentioned in: Isolation with Acinetobacter (10-14). Furthermore, most studies do not differentiate outcomes of patients infected with MDR Acinetobacter from those infected with drug-susceptible Acinetobacter. This finding leads to questions about the merits of targeting infection control measures to control MDR Acinetobacter To determine the effect of MDR Acinetobacter infection on mortality rates, length of hospital stay, and length of intensive care unit (ICU ICU intensive care unit.
intensive care unit
see intensive care unit.
ICU ) stay, the University of Maryland University of Maryland can refer to:
In medicine, it is usually undertaken to obtain evidence to try to refute the existence of a suspected association between cause and disease; failure to refute in Baltimore, Maryland "Baltimore" redirects here. For the surrounding county, see Baltimore County, Maryland. For other uses, see Baltimore (disambiguation).
Baltimore is an independent city located in the state of Maryland in the United States. . This is the first study that directly examines the effect of multidrug
resistance on outcomes of Acinetobacter infections while controlling for severity of illness.
A retrospective, matched cohort investigation was performed by using patient records from January 2003 through August 2004 from 2 tertiary care tertiary care Managed care The most specialized health care, administered to Pts with complex diseases who may require high-risk pharmacologic regimens, surgical procedures, or high-cost high-tech resources; TC is provided in 'tertiary care centers', often hospitals in Baltimore to examine outcomes of hospitalized patients with MDR Acinetobacter infection (exposure) compared with 2 unexposed reference groups: patients with susceptible Acinetobacter infection (susceptible references) and patients without Acinetobacter infection (uninfected references). We chose 2 reference groups to explore the effects of multidrug resistance multidrug resistance,
n the adaptation of tumor cells or infectious agents to resist chemotherapeutic agents. and MDR Acinetobacter infection on patient outcomes (15). We defined MDR Acinetobacter as organisms resistant to all or all but 1 antimicrobial drug classes commonly prescribed to treat gram-negative infections. Susceptibility to polymyxins was not considered in these criteria because susceptibility testing susceptibility test Antimicrobial susceptibility test, see there for these drugs is not routinely performed. We defined susceptible Acinetobacter as organisms susceptible to [less than or equal to] 3 antimicrobial classes. Those patients infected with Acinetobacter that was susceptible to only 2 antimicrobial drug classes were excluded.
A computer-generated list was used to identify all persons from whom MDR Acinetobacter had been recovered from January 2003 through August 2004. Charts were then reviewed to determine, on the basis of criteria set forth by the National Nosocomial Infection Nosocomial infection
An infection that can be acquired in a hospital. ABPA is a nosocomial infection.
Mentioned in: Allergic Bronchopulmonary Aspergillosis, Hospital-Acquired Infections, Pseudomonas Infections
Surveillance System (NNIS NNIS National Nosocomial Infection Surveillance System ) (16), if the patient had 1 of the following infections caused by MDR Acinetobacter: bloodstream, pneumonia (respiratory tract respiratory tract
The air passages from the nose to the pulmonary alveoli, including the pharynx, larynx, trachea, and bronchi.
Respiratory tract ), surgical site, urine, or sterile site other than blood. Admitted patients with both healthcare-acquired (i.e., infection was diagnosed >48 h after hospital admission) and community-acquired Acinetobacter infections (i.e., infection was diagnosed within 48 h of hospital admission) were included.
For the selection of matched susceptible references, microbiology records were reviewed to identify patients from whom susceptible Acinetobacter had been recovered from January 2003 through August 2004 at each institution. NNIS definitions were then applied to identify Acinetobacter-infected patients who were included in the study (16). To ensure that susceptible references and their matched MDR Acinetobacter patients had a similar exposure time, the susceptible references had to have a preinfection length of hospital stay within 5% of the matched MDR Acinetobacter patient's preinfection length of stay. Patients infected with MDR Acinetobacter were matched to susceptible references from the same institution.
The second reference group, uninfected patients, included patients without Acinetobacter infection who had a length of hospital stay (time between admission and discharge) at least as long as the preinfection length of stay of the respective matched patient infected with MDR Acinetobacter. The matched uninfected patient also had to be present in the ward where the patient infected with MDR Acinetobacter was located within 30 days of becoming infected with MDR Acinetobacter.
Data abstracted from medical records included demographic information; presence of prior and concurrent medical conditions See carpal tunnel syndrome, computer vision syndrome, dry eyes and deep vein thrombosis. ; dates of admission and discharge to the ICU and hospital; date and time of Acinetobacter culture; Acinetobacter antimicrobial susceptibility pattern; length of stay before infection (exposure time); presence or absence of concordant antimicrobial therapy on the day of the Acinetobacter culture (based on the susceptibility pattern of the organism); patient status on day of discharge; and date and cause of death if applicable. Data were collected on the following outcomes: in-hospital mortality rates and total number of days in hospital and ICU after the index day (i.e., length of stay after the exposure). We defined the index day as either the day of hospitalization on which Acinetobacter infection was diagnosed for patients infected with MDR Acinetobacter and for susceptible reference patients or the same day of hospitalization for uninfected patients. For example, if an MDR Acinetobacter infection was diagnosed on hospital day 15, that would be the index day for the MDR Acinetobacter patient and for the matched, uninfected patient.
To control for severity of illness before Acinetobacter infection, data were collected to calculate a modified Acute Physiology and Chronic Health Evaluation III (APACHE) score (17,18) [approximately equal to] 48 h before the index day. Our modified APACHE score did not include blood pH, pulmonary arterial oxygen saturation oxygen saturation sO2 The O2 concentration of blood expressed as a ratio of its total O2-carrying capacity; the OS is a measure of the utilization of O2 transport capacity; sO2 , pulmonary arterial gradient, urine output, or scoring for neurologic neurologic /neu·ro·log·ic/ (-loj´ik) pertaining to neurology or to the nervous system.
Having to do with the nervous system. abnormalities. These parameters were excluded because they were not uniformly available for all patients in the study, particularly for those not in the ICU. To control for underlying disease, a Charlson comorbidity index (19) was calculated by using data from the medical history recorded on the chart.
All data were collected on standard forms, entered into an Access database (Microsoft, Redmond, WA, USA) and analyzed with SAS (1) (SAS Institute Inc., Cary, NC, www.sas.com) A software company that specializes in data warehousing and decision support software based on the SAS System. Founded in 1976, SAS is one of the world's largest privately held software companies. See SAS System. software (SAS Institute SAS Institute Inc., headquartered in Cary, North Carolina, USA, has been a major producer of software since it was founded in 1976 by Anthony Barr, James Goodnight, John Sall and Jane Helwig. , Cary, NC, USA). Demographic data were analyzed with Mantel-Haenszel relative risks and 95% confidence intervals (CIs) to compare categorical variables and the Wilcoxon 2-sample test with t approximation to compare continuous variables. Matched univariate analysis was performed by using conditional logistic regression In statistics, logistic regression is a regression model for binomially distributed response/dependent variables. It is useful for modeling the probability of an event occurring as a function of other factors. . Multivariable analysis controlling for severity of illness with the APACHE score and underlying diseases with the Charlson index was performed by using conditional logistic regression to evaluate inhospital mortality rate and hospital and ICU length of stay.
To create a dichotomous di·chot·o·mous
1. Divided or dividing into two parts or classifications.
2. Characterized by dichotomy.
di·chot variable for ICU and hospital lengths of stay, we compared the number in each comparison group that had a length of stay greater than the combined mean of the 2 groups being compared. For example, the combined group of MDR Acinetobacter-infected and susceptible Acinetobacter references had a mean hospital length of stay of 23 days after the index day (day of infection). The number of MDR Acinetobacter patients who had a hospital length of stay >23 days was then compared with the number of susceptible references who had a hospital length of stay >23 days, while controlling for severity of illness and associated underlying diseases in the multivariable model. We chose to compare against the mean rather than the median length of stay to account for outliers. Unmatched MDR Acinetobacter--infected and reference patients were excluded from the groups before the mean was calculated. A linear regression Linear regression
A statistical technique for fitting a straight line to a set of data points. model and an ordinal (mathematics) ordinal - An isomorphism class of well-ordered sets. logistic regression model were also attempted; however, these models could not be used because the outcome data were not normally distributed and could not be transformed appropriately for linear regression and because the assumptions for the ordinal logistic regression model could not be satisfied.
To examine the effect of discordant dis·cor·dant
1. Not being in accord; conflicting.
2. Disagreeable in sound; harsh or dissonant.
dis·cor empiric antimicrobial drug therapy on clinical outcomes, multivariable analysis was performed on the MDR Acinetobacter patients alone; the exposure evaluated was concordant versus discordant empiric antimicrobial drug therapy. Outcomes included mortality rate, length of hospital stay, and ICU stay. We defined discordant empiric antimicrobial drug therapy as the administration of antimicrobial drug(s) to which the Acinetobacter strain was not susceptible. Concordant empiric antimicrobial drug therapy is defined as the administration of antimicrobial drug(s) to which the Acinetobacter strain was susceptible. APACHE and Charlson index scores were included in the model to control for their effect on outcomes.
Effect modification effect modification Epidemiology An interaction among multiple possible cause-and-effect relationships, where the estimate of the effect of one factor on a disease process depends on other factors in the study between MDR Acinetobacter reference groups and APACHE and Charlson index variables was evaluated by testing appropriate interaction terms for statistical significance. All statistical tests were 2-tailed; a p value [less than or equal to] 0.05 was considered statistically significant.
From January 2003 through August 2004, a total of 166 patients had cultures that grew MDR Acinetobacter, and 96 (58%) met the NNIS criteria for an MDR Aeinetobacter infection (16). Of the MDR isolates, 88 (92%) were not susceptible to carbapenems.
MDR Acinetobacter--infected Patients Compared with Susceptible References
We identified 91 reference patients infected with susceptible Acinetobacter who had similar lengths of hospital stay before the index day as MDR Acinetobacter--infected patients. Five MDR Acinetobacter--infected patients were excluded from the analysis because reference patients could not be identified due to a lack of susceptible references who were hospitalized for long periods. MDR Acinetobacter patients and susceptible references were similar in age and sex; however, MDR Acinetobacter patients had higher baseline mean APACHE and Charlson index scores than susceptible references (Table 1). The distribution of culture sites among MDR Acinetobacter and susceptible reference patients was similar; [approximately equal to] 50% of each group had respiratory infections, 31% in each group had bloodstream infections, and <10% of both groups had surgical wound, urinary tract, or other sterile site infections (p not significant for all comparisons). A total of 78 (81%) MDR Acinetobacter infections and 73 (80%) susceptible Acinetobacter infections were identified >48 h after hospital admission and thus met criteria for nosocomial infection.
Matched univariate analysis of patient outcomes showed that MDR Acinetobacter--infected patients had higher mean lengths of hospital stay and ICU stay after the index day than susceptible and uninfected references (Table 2). In-hospital mortality rates for patients with MDR Acinetobacter infections (26%) were higher than for susceptible references (18%) and uninfected references (11%). However, only the difference between MDR Acinetobacter--infected patients and uninfected patients was statistically significant (Table 2). When controlling for severity of illness with the APACHE score and for underlying disease with the Charlson index in a conditional logistic regression model, association with a longer hospital and ICU length of stay was approximately twice as likely for patients with MDR Acinetobacter infection as for susceptible references (Table 3). Multivariable analysis controlling for severity of illness with the APACHE score and underlying diseases with the Charlson index showed a trend toward more deaths associated with infection with MDR Acinetobacter than with infection with susceptible Acinetobacter, but the difference was not statistically significant (relative risk 2.6, 95% CI 0.3-26.1) (Table 3).
Discordant antimicrobial drug therapy was more common for MDR Acinetobacter--infected patients than for susceptible references (91% vs. 65%, p<0.001). When we controlled for severity of illness and underlying diseases, we found that initial discordant antimicrobial drug therapy was not associated with increased mortality rates or hospital length of stay among patients infected with MDR Acinetobacter (Table 4). However, patients infected with MDR Acinetobacter who were treated with initial discordant antimicrobial drug therapy were >5x as likely to be associated with an increased ICU length of stay.
MDR Acinetobacter--infected Patients Compared with Uninfected References
Uninfected reference patients were identified for 89 of 96 patients with MDR Acinetobacter infections. Reference patients were not identified for 7 MDR Acinetobacter patients because there were not enough uninfected patients with extensive hospital lengths of stay. MDR Acinetobacter--infected patients and uninfected references were similar in age and sex. However, patients with MDR Acinetobacter infection had higher baseline mean APACHE and Charlson index scores than references (Table 1). Matched univariate analysis of patient outcomes showed that patients with MDR Acinetobacter had higher in-hospital mortality rates (26% vs. 11%, p<0.01) and mean hospital and ICU lengths of stay after the index day than uninfected references (Table 2). When we controlled for severity of illness and underlying conditions, we found that MDR Acinetobacter--infected patients were more likely to have both longer hospital and ICU lengths of stay than uninfected references (Table 3).
Acinetobacter is emerging as an important pathogen Pathogen
Any agent capable of causing disease. The term pathogen is usually restricted to living agents, which include viruses, rickettsia, bacteria, fungi, yeasts, protozoa, helminths, and certain insect larval stages. in traditional and nontraditional healthcare settings. Its ability to infect healthy hosts and its propensity to develop antimicrobial drug resistance have caused concern among the infectious diseases infectious diseases: see communicable diseases. community. Our study assessed the clinical outcomes of patients infected with MDR Acinetobacter compared with outcomes of patients infected with susceptible Acinetobacter strains and patients without Acinetobacter infections among a large cohort. We demonstrated that patients infected with MDR strains of Acinetobacter have longer lengths of stay in both the hospital and ICU than patients infected with drug-susceptible Acinetobacter and patients without Acinetobacter infection when we controlled for severity of illness. We found a trend toward increased mortality rates among patients with MDR Acinetobacter infection. However, the difference was not statistically significant when we controlled for severity of illness.
According to according to
1. As stated or indicated by; on the authority of: according to historians.
2. In keeping with: according to instructions.
3. NNIS, Acinetobacter species caused 7% of ICU healthcare-associated pneumonias in 2003 compared with 4% in 1986 (p<0.001) (4). The proportion of ICU healthcare-associated urinary tract infections urinary tract infection (UTI),
n infection in one or more of the structures that make up the urinary system. Occurs more often in women and is most commonly caused by bacteria. and surgical site infections caused by Acinetobacter also increased significantly from 1986 to 2003 (p<0.001) (4). Furthermore, the proportions of Acinetobacter isolates reported to NNIS that were resistant to ceftazidime, amikacin, and imipenem all increased significantly during that period (p<0.001). Healthcare-associated outbreaks of MDR Acinetobacter infection have been reported in Asia, Europe, North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. , and among US service members injured in the Middle East (7-9). These findings have brought control of MDR Acinetobacter infections to the forefront of discussion.
Investigating the effect of multidrug resistance on clinical outcomes presents multiple methodologic challenges that have been explicitly addressed in our study design. Confounding confounding
when the effects of two, or more, processes on results cannot be separated, the results are said to be confounded, a cause of bias in disease studies.
confounding factor risk factors associated with mortality rates and antimicrobial drug resistance, such as age, severity of illness, and underlying disease (18-21) must be controlled for in the study design or analysis. Our results differ from those of researchers who examined outcomes of Acinetobacter infections without controlling for these confounders (14,22,23), which makes their findings difficult to interpret. We assessed and controlled for severity of illness and underlying disease with 2 measurements: the APACHE score, which included age, physiologic parameters, and selected underlying diseases; and a separate Charlson index, which included a broader range of underlying diseases. Both measurements have been validated, although the APACHE score has only been studied in its original form (19,21,24). Because patients infected with Acinetobacter have worse clinical outcomes than those who are colonized with the organism (11), we separated Acinetobacter infection from colonization colonization, extension of political and economic control over an area by a state whose nationals have occupied the area and usually possess organizational or technological superiority over the native population. on the basis of standardized, validated Centers for Disease Control and Prevention (Atlanta, GA, USA) NNIS definitions for nosocomial infection (16,25) and applied them uniformly to MDR Acinetobacter and susceptible references. We compared outcomes of MDR Acinetobacter infections with those of 2 reference groups and showed an association of MDR Acinetobacter infection with both increased hospital and ICU lengths of stay, regardless of the reference group selected. As one would predict on the basis of results of a study by Kaye et al., the effect of multi-drug resistance was greater compared with uninfected than susceptible references (15).
Because of the lack of a standard definition for multi-drug resistance in the literature, we defined multidrug resistance as resistance to all or all but 1 antimicrobial drug class commonly prescribed for treatment of patients with gram-negative infections, with the exclusion of polymyxins (26). This definition has 2 advantages. First, it is a strict standard and is readily accepted by clinicians as representative of multidrug resistance. Second, it allows for a clear distinction between susceptible and MDR Acinetobacter strains because we excluded isolates that showed intermediate resistance (strains resistant to all but 2 commonly prescribed antimicrobial drug classes).
The association of MDR Acinetobacter infections with worse clinical outcomes could be related to discordant empiric antimicrobial drug therapy. Previous studies that examined the effects of delayed concordant antimicrobial therapy on patient outcomes have shown conflicting results (27-29). We examined this issue and found that patients with MDR Acinetobacter infections who received discordant empiric antimicrobial drug therapy were not more likely to die or have a longer hospital length of stay than patients who received concordant empiric drug therapy; however, they were more likely to have a longer ICU length of stay. On the basis of these results, to what extent discordant empiric antimicrobial drug therapy affects clinical outcomes of MDR Acinetobacter infection is not clear.
Determining optimal infection control approaches to MDR Acinetobacter has been complicated by the lack of agreement on the clinical significance of Acinetobacter infections. The Hospital Infection Control Practices Advisory Committee guideline for isolation precautions in hospitals recommends targeting increased infection control efforts toward "resistant bacteria judged by the infection control program to be of special clinical and epidemiologic significance" (30). We found that MDR Acinetobacter infections are independently associated with increased hospital and ICU lengths of stay. This finding, combined with increased risk for in-hospital transmission of the organism (31), supports recommendations to implement aggressive control measures to limit the transmission of MDR Acinetobacter in healthcare settings.
Several limitations of this study merit discussion. Because of the lack of available data to calculate a standard APACHE III APACHE III Acute Physiology & Chronic Health Evaluation Intensive care A 'third-generation' system for estimating the risk of hospital death in adult ICU Pts based on physiological assessments of most severely affected values during the first 24 hrs in the ICU score for non-ICU patients, we modified the APACHE III score by excluding variables that were unavailable for non-ICU patients. However, our findings support the validity of this scoring system Noun 1. scoring system - a system of classifying according to quality or merit or amount
classification system - a system for classifying things as a measure for severity of underlying illness. Mean APACHE scores were higher in MDR Acinetobacter--infected patients than in both reference groups and progressed stepwise stepwise
incremental; additional information is added at each step.
stepwise multiple regression
used when a large number of possible explanatory variables are available and there is difficulty interpreting the partial regression from no infection to MDR infection. These findings are expected because drug-resistant infections reportedly occur in sicker patients (24,32,33). Univariate analysis showed that a modified APACHE score was also associated with mortality rates (p<0.001), which further supports its validity as a measure of illness severity.
The lack of available reference patients with similar exposure times to several of the case-patients (5 susceptible references and 7 uninfected references) was a second limitation because we were obligated ob·li·gate
tr.v. ob·li·gat·ed, ob·li·gat·ing, ob·li·gates
1. To bind, compel, or constrain by a social, legal, or moral tie. See Synonyms at force.
2. To cause to be grateful or indebted; oblige. to exclude unmatched MDR Acinetobacter--infected patients from our analysis. These excluded patients typically had prolonged exposure times and tended to have long hospital and ICU lengths of stay after infection. Exclusion of these patients decreased the power of our study and likely biased our results toward showing no difference in hospital or ICU length of stay between the groups. Finally, the lack of a difference in mortality rates, according to multivariable analysis, could mean that MDR Acinetobacter are not more virulent vir·u·lent
1. Extremely infectious, malignant, or poisonous. Used of a disease or toxin.
2. Capable of causing disease by breaking down protective mechanisms of the host. Used of a pathogen.
3. than nonresistant non·re·sis·tant
1. Not resistant, especially to a disease or environmental factor, such as heat or moisture.
2. Submissively obedient. strains or that the sample size in this study lacked the power to show a difference.
Our study indicates that infections with MDR Acinetobacter are independently associated with the adverse clinical outcomes of prolonged hospital and ICU lengths of stay compared with the outcomes for uninfected patients and those infected with drug-susceptible Acinetobacter. This is the first study evaluating length of stay and mortality rates associated with MDR Acinetobacter infection while controlling for important confounders such as severity of illness and underlying disease. These data emphasize the need for aggressive infection control strategies to prevent MDR Acinetobacter infection and its adverse effects on hospitalized patients.
We thank David Blythe and the Maryland Department of Health and Mental Hygiene in Baltimore, Maryland, for their support of and assistance with this investigation.
This study was supported by the Centers for Disease Control and Prevention (CDC See Control Data, century date change and Back Orifice.
CDC - Control Data Corporation ). Lisa L. Maragakis was supported by grant 1 K01 CI000300-1 from CDC.
(1.) Jawad A, Snelling Snelling can refer to: People
The process of being desiccated.
desic·ca tolerance of Acinetobacter radioresistens. J Hosp Infect. 1998;39:23540.
(2.) Hirai Y. Survival of bacteria under dry conditions; from a viewpoint of nosocomial infection. J Hosp Infect. 1991;19:191-200.
(3.) Guenthner SH, Hendley JO, Wenzel RP. Gram-negative bacilli as nontransient flora on the hands of hospital personnel. J Clin Microbiol. 1987;25:488-90.
(4.) Gaynes R, Edwards JR. Overview of nosocomial infections Nosocomial infections
Infections that were not present before the patient came to a hospital, but were acquired by a patient while in the hospital.
Mentioned in: Enterobacterial Infections, Staphylococcal Infections caused by gram-negative bacilli. Clin Infect Dis. 2005;41:848-54.
(5.) Manikal VM, Landman D, Saurina G, Oydna E, Lal H, Quale qua·le
n. pl. qua·li·a
A property, such as whiteness, considered independently from things having the property.
[From Latin qu J. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of : citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis. 2000;31:101-6.
(6.) Mahgoub S, Ahmed J, Glatt Glatt may refer to:
(7.) Hsueh PR, Teng LJ, Chen CY, Chen WH, Yu CJ, Ho SW, et al. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan. Emerg Infect Dis. 2002;8:827-32.
(8.) Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol. 2003;24:284-95.
(9.) Centers for Disease Control and Prevention. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR MMWR Morbidity & Mortality Weekly Report Epidemiology A news bulletin published by the CDC, which provides epidemiologic data–eg, statistics on the incidence of AIDS, rabies, rubella, STDs and other communicable diseases, causes of mortality–eg, Morb Mortal Wkly Rep. 2004;53:1063-6.
(10.) Gamacho J, Sole-Violan J, Sa-Borges M, Diaz E, Rello Rello is a municipality located in the province of Soria, Castile and León, Spain. According to the 2004 census (INE), the municipality has a population of 33 inhabitants. J. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit Care Med. 2003;31:2478-82.
(11.) Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez FJ, Monterrubio-Villar J, Gili-Miner M. Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med. 1999;27:1794-9.
(12.) Blot S, Vandewoude K, Colardyn F. Nosocomial nosocomial /noso·co·mi·al/ (nos?o-ko´me-il) pertaining to or originating in a hospital.
1. Of or relating to a hospital.
2. bacteremia bacteremia: see septicemia.
Presence of bacteria in the blood. Short-term bacteremia follows dental or surgical procedures, especially if local infection or very high-risk surgery releases bacteria from isolated sites. involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med. 2003;29:471-5.
(13.) Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P, et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis. 1995;20:790-6.
(14.) The Brooklyn Antibiotic Resistance antibiotic resistance,
n the ability of certain strains of microorganisms to develop resistance to antibiotics.
antibiotic resistance Task Force. The cost of antibiotic resistance: effect of resistance among Staphylococcus aureus Staphylococcus au·re·us
A bacterium that causes furunculosis, pyemia, osteomyelitis, suppuration of wounds, and food poisoning.
Staphylococcus aureus Staphylococcus pyogenes , Klehsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa Pseudomonas aeruginosa A normal soil inhabitant and human saprophyte that may contaminate various solutions in a hospital, causing opportunistic infection in weakened Pts Clinical Infective endocarditis in IVDAs, RTIs, UTIs, bacteremia, meningitis, 'malignant' on length of hospital stay. Infect Control Hosp Epidemiol. 2002;23:106-8.
(15.) Kaye KS, Engemann JJ, Mozaffari E, Carmeli Y. Reference group choice and antibiotic resistance outcomes. Emerg Infect Dis. 2004;10:1125-8.
(16.) Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall CG, editor. Hospital epidemiology and infection control. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 1659-702.
(17.) Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, et al. The APACHE Ill prognostic prog·nos·tic
1. Of, relating to, or useful in prognosis.
2. Of or relating to prediction; predictive.
1. A sign or symptom indicating the future course of a disease.
2. system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619-36.
(18.) Chen Y-C, Chen C-Y, Hsu H-H, Yang C-W, Fang J-T. APACHE III scoring system in critically ill patients with acute renal failure acute renal failure Acute kidney failure Nephrology An abrupt decline in renal function, triggered by various processes–eg, sepsis, shock, trauma, kidney stones, drug toxicity-aspirin, lithium, substances of abuse, toxins, iodinated radiocontrast. requiring dialysis. Dialysis and Transplantation. 2002;31:222-33.
(19.) Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies longitudinal studies,
n.pl the epidemiologic studies that record data from a respresentative sample at repeated intervals over an extended span of time rather than at a single or limited number over a short period. : development and validation. J Chronic Dis. 1987;40:373-83.
(20.) Niederman MS. Impact of antibiotic resistance on clinical outcomes and the cost of care. Crit Care Med. 2001;29(4 Suppl):N114-20.
(21.) Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II APACHE II ("Acute Physiology and Chronic Health Evaluation II") is a severity of disease classification system (Knaus et al., 1985), one of several ICU scoring systems. After admission of a patient to an intensive care unit, an integer score from 0 to 71 is computed based on : a severity of disease classification system. Crit Care Med. 1985;13:818-29.
(22.) Wisplinghoff H, Edmond MB, Pfaller MA, Jones RN, Wenzel RP, Seifert H. Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology molecular epidemiology Molecular medicine An evolving field that combines the tools of standard epidemiology–case studies, questionnaires and monitoring of exposure to external factors with the tools of molecular biology–eg, restriction endonucleases, , and antimicrobial susceptibility. Clin Infect Dis. 2000;31:690-7.
(23.) Fagon JY, Chastre J, Domart Y, Trouillet JL, Gibert C. Mortality due to ventilator-associated pneumonia Ventilator-associated pneumonia (VAP) is a sub-type of hospital-acquired pneumonia (HAP) which occurs in people who are on mechanical ventilation through an endotracheal or tracheostomy tube for at least 48 hours. or colonization with Pseudomonas Pseudomonas
A genus of gram-negative, nonsporeforming, rod-shaped bacteria. Motile species possess polar flagella. They are strictly aerobic, but some members do respire anaerobically in the presence of nitrate. or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush. Clin Infect Dis. 1996;23:538-42.
(24.) Lesens O, Methlin C, Hansmann Y, Remy V, Martinot M, Bergin C, et al. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol. 2003;24:890-6.
(25.) Emori TG, Edwards JR, Culver DH, Sartor C, Stroud LA, Gaunt gaunt
thin plus obvious diminution in abdominal size, indicative of reduced feed intake leading to reduced gut fill. EE, et al. Accuracy of reporting nosocomial infections in intensive-careunit patients to the National Nosocomial Infections Surveillance System: a pilot study. Infect Control Hosp Epidemiol. 1998;19:308-16.
(26.) Sunenshine RH, Liedtke LA, Srinivasan A, Jernigan DB. Strausbaugh LJ and the IDSA IDSA Infectious Diseases Society of America
IDSA Industrial Designers Society of America
IDSA Interactive Digital Software Association
IDSA Institute for Defense Studies and Analyses (India)
IDSA International Dark Sky Association Emerging Infections Network. Multidrug-resistant gram-negative bacilli: limited options for treatment. In: Abstracts of the 15th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; Los Angeles Los Angeles (lôs ăn`jələs, lŏs, ăn`jəlēz'), city (1990 pop. 3,485,398), seat of Los Angeles co., S Calif.; inc. 1850. , California; 2005 April 9-12; Abstract 101. Alexandria, (VA): Society for Healthcare Epidemiology of America; 2005.
(27.) Hyle EP, Lipworth AD, Zaoutis TE, Nachamkin I, Bilker WB, Lautenbach E. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection. Arch Intern intern /in·tern/ (in´tern) a medical graduate serving in a hospital preparatory to being licensed to practice medicine.
in·tern or in·terne
n. Med. 2005; 165:1375-80.
(28.) Zaragoza R, Artero A, Camarena JJ, Sancho S, Gonzalez R, Nogueira JM. The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit. Clin Microbiol Infect. 2003;9:412-8.
(29.) Lee SC, Hua CC, Yu TJ, Shieh WB, See LC. Risk factors of mortality for nosocomial pneumonia nosocomial pneumonia An infection of lungs–bronchoalveolar unit–in a Pt who has been hospitalized ≥ 48 hrs, and directly attributable to pathogens acquired during the hospital visit Etiology Pseudomonas spp, S aureus, Legionella : importance of initial anti-microbial therapy. Int J Clin Pract. 2005;59:39-45.
(30.) Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1996;17:53-80.
(31.) D'Agata EM, Thayer V, Schaffner W. An outbreak of Acinetobacter baumannii: the importance of cross-transmission. Infect Control Hosp Epidemiol. 2000;21:588-91.
(32.) Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin methicillin /meth·i·cil·lin/ (meth?i-sil´in) a semisynthetic penicillin highly resistant to inactivation by penicillinase; used as the sodium salt.
n. resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol. 2005;26:166-74.
(33.) Song X, Srinivasan A, Plaut D, Perl TM. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infect Control Hosp Epidemiol. 2003;24:251-6.
Rebecca H. Sunenshine, * Marc-Oliver Wright, ([dagger]) Lisa L. Maragakis, ([doubledagger]) Anthony D. Harris, ([dagger]) Xiaoyan Song, ([doubledagger]) Joan Hebden, ([dagger]) Sara E. Cosgrove, ([doubledagger]) Ashley Anderson, * Jennifer Carnell, * Daniel B. Jernigan, * David G. Kleinbaum, * Trish M. Perl, ([doubledagger]) Harold C. Standiford, ([dagger]) and Arjun Srinivasan *
* Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ([dagger]) University of Maryland Medical School and Medical Center, Baltimore, Maryland, USA; and ([double dagger double dagger
A reference mark () used in printing and writing. Also called diesis.
Noun 1. ]) Johns Hopkins University Johns Hopkins University, mainly at Baltimore, Md. Johns Hopkins in 1867 had a group of his associates incorporated as the trustees of a university and a hospital, endowing each with $3.5 million. Daniel C. , Baltimore, Maryland, USA
Dr Sunenshine is a medical epidemiologist in the Epidemic Intelligence Service The Epidemic Intelligence Service is a program of the United States' Centers for Disease Control and Prevention. Established in 1951 due to biological warfare concerns arising from the Korean War, it has become a hands-on two-year postgraduate training program in epidemiology, with in the Division of Healthcare Quality Promotion at CDC. Her research focuses on healthcare-associated infections and antimicrobial drug resistant organisms.
Address for correspondence: Arjun Srinivasan, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop A35, Atlanta, GA 30333, USA; email: firstname.lastname@example.org
Table 1. Comparison of baseline characteristics of patients with multidrug-resistant (MDR) Acinetobacter infection with those with susceptible Acinetobacter infection and those without Acinetobacter infection, Baltimore hospitals, 2003-2004 * MDR Susceptible p values for MDR Acinetobacter, Acinetobacter, Acinetobacter vs. Characteristic n = 96 n = 91 susceptible, n = 187 Median age, y 54 52 0.61 Age range, y 14-83 12-85 Sex, % male 67 57 0.78 Mean modified 41 (42) 36 (33) 0.02 APACHE III score (median) Mean Charlson 3.9 (3.0) 2.8 (2.0) 0.01 index (median) p values for MDR Uninfected, Acinetobacter vs. Characteristic n = 89 uninfected, n = 185 Median age, y 52 0.97 Age range, y 17-90 Sex, % male 65 0.96 Mean modified 32 (28) <0.001 APACHE III score (median) Mean Charlson 2.5 (2.0) <0.01 index (median) * APACHE III, Acute Physiology and Chronic Health Evaluation III. Table 2. Matched univariate analysis comparing outcomes of patients with multidrug-resistant (MDR) Acinetobacter infection with those with susceptible Acinetobacter infection and those without Acinetobacter infection, Baltimore hospitals, 2003-2004 p values for MDR MDR Susceptible Acinetobacter Acinetobacter, Acinetobacter vs. susceptible, Outcome evaluated n = 96 n = 91 n = 182 Mean length of stay 27.5 19.8 0.02 after index day, d Mean intensive care 13.3 6.7 0.04 unit length of stay after index day, d Mortality rate (%) 26.0 17.6 0.21 p values for MDR Uninfected, Acinetobacter vs. Outcome evaluated n = 89 uninfected, n = 178 Mean length of stay 18.6 <0.01 after index day, d Mean intensive care 7.3 <0.01 unit length of stay after index day, d Mortality rate (%) 11.2 <0.01 Table 3. Multivariable analysis of outcomes of patients with and without multidrug-resistant (MDR) Acinetobacter infections, Baltimore hospitals, 2003-2004 * MDR Acinetobacter MDR Acinetobacter vs. susceptible vs. uninfected ([dagger]) ([dagger]) Outcome evaluated OR (95% CI) OR (95% CI) Length of stay, d 2.5 (1.2-5.2) 2.5 (1.2-5.4) Intensive care unit 2.1 (1.0-4.3) 4.2 (1.5-11.6) length of stay, d Mortality rate (%) 2.6 (0.3-26.1) 6.6 (0.4-108.3) * OR, odds ratio; CI, confidence interval. ([dagger]) Models include modified Acute Physiology and Chronic Health Evaluation III score to control for severity of illness and Charlson index to control for underlying disease. Table 4. Multivariable analysis of discordant versus concordant empiric antimicrobial drug therapy in patients with multidrug-resistant Acinetobacter infections, Baltimore hospitals, 2003-2004 * Discordant vs. concordant empiric antimicrobial drug therapy ([dagger]) Outcome evaluated OR (95% CI) p value Length of stay, d 1.6 (0.4-6.5) 0.54 Intensive care unit 5.8 (1.2-27.1) 0.03 length of stay, d Mortality rate (%) 0.7 (0.1-4.5) 0.74 * OR, odds ratio; CI, confidence interval. ([dagger]) Model includes modified Acute Physiology and Chronic Health Evaluation III score to control for severity of illness and Charlson index to control for underlying disease.